WIBP-CorV (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "WIBP-CorV" in Serbian language version.

refsWebsite

Global rank Serbian rank

4doi.org

2^nd place

4^th place

2worldcat.org

5^th place

12^th place

2clinicaltrials.gov

5,225^th place

6,444^th place

2nih.gov

4^th place

8^th place

1who.int

195^th place

154^th place

1wiley.com

222^nd place

155^th place

1nmpa.gov.cn

low place

1web.archive.org

1^st place

1channelnewsasia.com

1,127^th place

4,757^th place

1reuters.com

49^th place

103^rd place

1nytimes.com

7^th place

25^th place

1mb.com.ph

1,231^st place

3,335^th place

channelnewsasia.com (Global: 1,127^th place; Serbian: 4,757^th place)

„Sinopharm's Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion doses”. CNA (на језику: енглески). Архивирано из оригинала 19. 11. 2021. г. Приступљено 2022-01-28.

clinicaltrials.gov (Global: 5,225^th place; Serbian: 6,444^th place)

China National Biotec Group Company Limited (29. 10. 2020). G42 Healthcare company, Abu Dhabi Health Services Company, Wuhan Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co Ltd.. „Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above”. clinicaltrials.gov.
Universidad Peruana Cayetano Heredia (3. 11. 2020). National University of San Marcos, Peru. „Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru (Covid-Peru)”. ClinicalTrials.gov. NCT04612972.

doi.org (Global: 2^nd place; Serbian: 4^th place)

Hassine, Ikbel Hadj (2021). „Covid-19 vaccines and variants of concern: A review”. Reviews in Medical Virology: e2313. ISSN 1099-1654. doi:10.1002/rmv.2313.
Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, et al. (јул 2021). „Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial”. JAMA. 326 (1): 35—45. doi:10.1001/jama.2021.8565 .
Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N,; et al. „(July 2021). "Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial". JAMA”. 326 (1): 35—45. PMC 8156175 . PMID 34037666. doi:10.1001/jama.2021.8565. .
Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z,; et al. „(September 2020). "Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials". JAMA”. 324 (10): 951—960. PMC 7426884 . PMID 32789505. doi:10.1001/jama.2020.15543. .

mb.com.ph (Global: 1,231^st place; Serbian: 3,335^th place)

„FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate”. Manila Bulletin (на језику: енглески). Приступљено 2022-01-28.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N,; et al. „(July 2021). "Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial". JAMA”. 326 (1): 35—45. PMC 8156175 . PMID 34037666. doi:10.1001/jama.2021.8565. .
Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z,; et al. „(September 2020). "Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials". JAMA”. 324 (10): 951—960. PMC 7426884 . PMID 32789505. doi:10.1001/jama.2020.15543. .

nmpa.gov.cn (Global: low place; Serbian: low place)

english.nmpa.gov.cn

„Two Chinese-developed COVID-19 vaccines under review”. National Medical Products Administration. 25. 2. 2021. Приступљено 11. 4. 2021.

nytimes.com (Global: 7^th place; Serbian: 25^th place)

Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee; Kristoffersen, Matthew (2020-06-10). „Coronavirus Vaccine Tracker”. The New York Times (на језику: енглески). ISSN 0362-4331. Приступљено 2022-01-28.

reuters.com (Global: 49^th place; Serbian: 103^rd place)

„China approves two more domestic COVID-19 vaccines for public use”. Reuters (на језику: енглески). 2021-02-25. Приступљено 2022-01-28.

web.archive.org (Global: 1^st place; Serbian: 1^st place)

„Sinopharm's Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion doses”. CNA (на језику: енглески). Архивирано из оригинала 19. 11. 2021. г. Приступљено 2022-01-28.

who.int (Global: 195^th place; Serbian: 154^th place)

cdn.who.int

Evidence Assessment: Sinopharm/BBIBP COVID-19 vaccine (PDF) (Presentation). Page 6: World Health Organization. 29. 4. 2021. Приступљено 10. 7. 2021. „Evaluated BBIBP-CorV & WIBP-CorV”

wiley.com (Global: 222^nd place; Serbian: 155^th place)

onlinelibrary.wiley.com

Hassine, Ikbel Hadj (2021). „Covid-19 vaccines and variants of concern: A review”. Reviews in Medical Virology: e2313. ISSN 1099-1654. doi:10.1002/rmv.2313.

worldcat.org (Global: 5^th place; Serbian: 12^th place)

Hassine, Ikbel Hadj (2021). „Covid-19 vaccines and variants of concern: A review”. Reviews in Medical Virology: e2313. ISSN 1099-1654. doi:10.1002/rmv.2313.
Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee; Kristoffersen, Matthew (2020-06-10). „Coronavirus Vaccine Tracker”. The New York Times (на језику: енглески). ISSN 0362-4331. Приступљено 2022-01-28.

WIBP-CorV (Serbian Wikipedia)

channelnewsasia.com (Global: 1,127th place; Serbian: 4,757th place)

clinicaltrials.gov (Global: 5,225th place; Serbian: 6,444th place)

doi.org (Global: 2nd place; Serbian: 4th place)

mb.com.ph (Global: 1,231st place; Serbian: 3,335th place)

nih.gov (Global: 4th place; Serbian: 8th place)